Medicare Enrolled
Dr. Alfonso Bello, MD
Rheumatology · Glenview, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bello from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bello?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bello
Dr. Alfonso Bello is a rheumatology specialist in Glenview, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bello performed 202,897 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bello received a total of $637,334 from 55 pharmaceutical and/or device companies across 2462 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bello is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in IL
$637,334 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗202,897
Medicare services
Top 3% in IL for rheumatology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
100,400 | $4 | $13 |
| Tocilizumab injection (Actemra) | 74,960 | $4 | $15 |
| Denosumab injection (Prolia/Xgeva) | 18,960 | $18 | $59 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,916 | $96 | $285 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
889 | $11 | $151 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
691 | $8 | $19 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
637 | $10 | $67 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
637 | $5 | $17 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
622 | $5 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
597 | $7 | $47 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
399 | $17 | $86 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
292 | $49 | $441 |
| Contrast dye for imaging, lower concentration | 263 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
181 | $138 | $400 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
174 | $28 | $207 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
145 | $126 | $377 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
116 | $63 | $334 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
108 | $70 | $205 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
98 | $59 | $170 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
96 | $11 | $81 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
71 | $215 | $1,240 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
59 | $12 | $89 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
57 | $13 | $118 |
| Measurement of dna antibody, single stranded | 57 | $11 | $97 |
| Rheumatoid factor level | 57 | $5 | $45 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
55 | $28 | $140 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
55 | $6 | $19 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
47 | $4 | $31 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
46 | $78 | $295 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $44 | $125 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
25 | $36 | $185 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
23 | $2 | $31 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
22 | $101 | $1,433 |
| Hyaluronan intra-articular injection An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning. |
21 | $562 | $1,819 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
19 | $48 | $196 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
17 | $44 | $178 |
| Knee X-ray, 4 or more views An imaging test using X-rays to create multiple pictures of the knee joint from different angles. |
16 | $43 | $176 |
| MRI of leg joint, without contrast A magnetic resonance imaging scan of a joint in the leg performed without the use of contrast dye. |
14 | $126 | $1,328 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $38 | $205 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
12 | $30 | $130 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
96.8% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$637,334
Total received (2018-2024)
Avg $91,048/year across 7 years
Top 1% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
2,462
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$54,879
2023
$56,297
2022
$86,463
2021
$54,982
2020
$69,563
2019
$208,064
2018
$107,085
Payments by company (2024)
Amgen Inc.
$26,489
Mallinckrodt Hospital Products Inc.
$11,284
ABBVIE INC.
$7,841
Fresenius Kabi USA, LLC
$4,805
Janssen Biotech, Inc.
$2,320
UCB, Inc.
$378
ANI Pharmaceuticals, Inc.
$319
Alexion Pharmaceuticals, Inc.
$300
Boehringer Ingelheim Pharmaceuticals, Inc.
$252
Novartis Pharmaceuticals Corporation
$168
GENZYME CORPORATION
$139
PFIZER INC.
$131
Sandoz Inc.
$61
AstraZeneca Pharmaceuticals LP
$61
Kyowa Kirin, Inc.
$55
E.R. Squibb & Sons, L.L.C.
$55
Lilly USA, LLC
$54
Genentech USA, Inc.
$50
Actelion Pharmaceuticals US, Inc.
$33
HOSPIRA, INC.
$28
Radius Health, Inc.
$24
Biocon Biologics Inc
$17
Celgene Corporation
$14
Top 3 companies account for 83.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$82,839
AbbVie, Inc.
$75,368
Mallinckrodt Hospital Products Inc.
$70,977
AbbVie Inc.
$70,219
Horizon Therapeutics plc
$59,517
Celgene Corporation
$59,227
ABBVIE INC.
$43,789
Amgen Inc.
$29,547
Mallinckrodt LLC
$23,326
Mallinckrodt Enterprises LLC
$22,887
Horizon Pharma plc
$20,795
PFIZER INC.
$16,178
Fresenius Kabi USA, LLC
$11,924
ANI Pharmaceuticals, Inc.
$11,585
UCB, Inc.
$8,267
GENZYME CORPORATION
$7,625
Ironwood Pharmaceuticals, Inc
$5,655
Janssen Biotech, Inc.
$3,936
Exeltis, USA Inc.
$2,732
Aurinia Pharma U.S., Inc.
$2,534
Regeneron Healthcare Solutions, Inc.
$1,113
MEDAC PHARMA, INC.
$944
E.R. Squibb & Sons, L.L.C.
$910
Lilly USA, LLC
$884
Antares Pharma, Inc.
$752
Collegium Pharmaceutical, Inc.
$671
Boehringer Ingelheim Pharmaceuticals, Inc.
$487
AstraZeneca Pharmaceuticals LP
$412
Alexion Pharmaceuticals, Inc.
$396
Hikma Pharmaceuticals USA
$233
Genentech USA, Inc.
$218
GlaxoSmithKline, LLC.
$203
Merz North America, Inc.
$157
Egalet US Inc
$147
Radius Health, Inc.
$125
Sandoz Inc.
$105
SANOFI-AVENTIS U.S. LLC
$91
Sebela Pharmaceuticals Inc.
$69
MEDEXUS PHARMA, INC.
$65
Janssen Scientific Affairs, LLC
$55
Kyowa Kirin, Inc.
$55
Actelion Pharmaceuticals US, Inc.
$46
HOSPIRA, INC.
$39
Organon LLC
$38
Ultragenyx Pharmaceutical Inc.
$26
Daiichi Sankyo Inc.
$23
Stimwave Technologies Incorporated
$23
Abbott Laboratories
$19
Pacira Therapeutics, Inc.
$19
Biocon Biologics Inc
$17
Pacira Pharmaceuticals Incorporated
$14
Purdue Pharma L.P.
$13
Eyevance Pharmaceuticals LLC
$13
Ferring Pharmaceuticals Inc.
$12
Takeda Pharmaceuticals U.S.A., Inc.
$11
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · ARYMO ER · Actemra · BENLYSTA · BEVESPI AEROSPHERE · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · ILARIS · IMFINZI · INFLECTRA · Iovera · KEVZARA · KRYSTEXXA · Kloxxado · LUPKYNIS · LYRICA · Mitigare · Morphabond ER · NO_PRODUCT · Nucynta · Nucynta ER · NucyntaER · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID 2 DICLOFENAC SODIUM TOPICAL SOLUTION · PRIMARY CARE - DISEASE STATE · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Prolia · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMPROIC · Stimufend · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tobradex ST · Tremfya · Tyenne · Tymlos · Uloric · XELJANZ · XTAMPZA · XTAMPZAER · XYOSTED · Xeomin · Xtampza ER · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
156
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
CHICAGO BEHAVIORAL HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bello is a mixed practice specialist, with above-average Medicare volume (top 3% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bello experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Bello performed 100,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bello receive payments from pharmaceutical companies?
Yes. Dr. Bello received a total of $637,334 from 55 companies across 2,462 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bello's costs compare to other rheumatologists in Glenview?
Dr. Bello's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bello) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Glenview
Browse rheumatologists in Glenview ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in IL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in IL
Which IL rheumatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology